Protective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis

Trial Profile

Protective Effect of Valproate on Brain Cells:A Magnetic Resonance Imaging and Spectroscopy Study in Patients With Bipolar Disorder Diagnosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jul 2009

At a glance

  • Drugs Valproic acid (Primary)
  • Indications Bipolar disorders
  • Focus Biomarker; Therapeutic Use
  • Sponsors Sanofi
  • Most Recent Events

    • 02 Jun 2009 Actual end date changed from Aug 2007 to Oct 2006 as reported by ClinicalTrials.gov.
    • 26 May 2009 Primay outcome amended as reported by ClinicalTrials.gov.
    • 26 May 2009 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top